0.07 \ m=+-\0.01 nmol\m=.\1\m=-\1 \ m=. \ mi n\ m=-\ 1; mean\m=+-\SEM, p < 0.01); in particular, this parameter was elevated in 18 of 30 patients (17-OHP(30\p=n-\0)/30min range = 0.23\p=n-\1.07vs 0.01\p=n-\0.19nmol\m=.\1\ m=-\ 1 \ m=. \ mi n\ m=-\ 1 in normal subjects). In a subset of 11 patients, serum markers of bone (bone-GLA protein (BGP) and carboxyterminal cross-linked telopeptide of type I collagen (ICTP) and collagen turnover (aminoterminal propeptide of type III procollagen (PIIINP)) were significantly (p < 0.01) lower than in normal subjects: in particular, in 2 preclinical Cushing's patients they were markedly reduced and rose after unilateral adrenalectomy. Of these 2 patients who underwent surgery, 1 showed a secondary hypoadrenalism. The histological study in 7 operated patients revealed the presence of benign adenoma in 4 cases and carcinoma, myelolipoma and hematoma in the others. In conclusion, in patients with incidentalomas endocrine testing is recommended because about two\x=req-\ thirds of them show subtle signs of adrenal overactivity. In patients with enzymatic defects of steroidogenesis a surgical approach is not suggested. On the contrary, the existence of a preclinical Cushing's syndrome has to be investigated carefully and followed up in order to disclose the possible appearance of clinical and/or metabolic features induced by the hypercortisolism and to suggest a surgical treatment.
17-OHP rate increase was higher than in normal subjects (17-OHP(30\p=n-\)/30min = 0.31 \m=+-\0.04vs 0.07 \ m=+-\0.01 nmol\m=.\1\m=-\1 \ m=. \ mi n\ m=-\ 1; mean\m=+-\SEM, p < 0.01); in particular, this parameter was elevated in 18 of 30 patients (17-OHP(30\p=n-\0)/30min range = 0.23\p=n-\1.07vs 0.01\p=n-\0.19nmol\m=.\1\ m=-\ 1 \ m=. \ mi n\ m=-\ 1 in normal subjects). In a subset of 11 patients, serum markers of bone (bone-GLA protein (BGP) and carboxyterminal cross-linked telopeptide of type I collagen (ICTP) and collagen turnover (aminoterminal propeptide of type III procollagen (PIIINP)) were significantly (p < 0.01) lower than in normal subjects: in particular, in 2 preclinical Cushing's patients they were markedly reduced and rose after unilateral adrenalectomy. Of these 2 patients who underwent surgery, 1 showed a secondary hypoadrenalism. The histological study in 7 operated patients revealed the presence of benign adenoma in 4 cases and carcinoma, myelolipoma and hematoma in the others. In conclusion, in patients with incidentalomas endocrine testing is recommended because about two\x=req-\ thirds of them show subtle signs of adrenal overactivity. In patients with enzymatic defects of steroidogenesis a surgical approach is not suggested. On the contrary, the existence of a preclinical Cushing's syndrome has to be investigated carefully and followed up (8) (9) (10) (11) (12) , but indicating the existence of a "preclinical" status of the syndrome that is now recognized more frequently (7, 13, 14) . In addition, a high incidence of adrenal masses has been found recently in a series of 22 patients with homozygous or heterozygous congenital adrenal hyperplasia (15) 
